|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 126.34 USD | +0.01% |
|
128.06 | +1.36% |
| 30/06 | Africa CDC seeks $18 million in urgent support for Ebola drug trials in DRC | RE |
| 30/06 | Gilead Sciences, Inc.(NasdaqGS:GILD) dropped from Russell 1000 Growth-Defensive Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.01% | +1.03% | -6.02% | -9.35% | +2.93% | +13.95% | +63.93% | +83.47% | +51.45% | 16TCr | |
| -2.48% | +8.34% | +8.55% | +30.41% | +11.61% | +53.87% | +155.75% | +422.58% | +1,423.09% | 1,07000Cr | |
| -1.76% | +6.23% | +12.71% | +3.90% | +22.72% | +66.27% | +53.44% | +54.16% | +109.37% | 61TCr | |
| -1.05% | +7.19% | +15.58% | +15.70% | +10.13% | +35.57% | +86.77% | +123.40% | +306.46% | 44TCr | |
| -1.11% | +4.18% | +2.88% | +7.66% | +3.23% | +31.11% | +23.88% | -2.80% | +32.29% | 33TCr | |
| +0.90% | +1.93% | +5.54% | -5.62% | +2.81% | +36.30% | +36.67% | +62.18% | +214.89% | 29TCr | |
| +0.25% | +1.95% | +11.29% | +3.14% | +15.66% | +29.48% | +43.17% | +50.15% | +57.56% | 29TCr | |
| +0.53% | +1.49% | +10.99% | +33.47% | -2.78% | -27.87% | -41.59% | +19.57% | +73.98% | 21TCr | |
| +0.44% | +4.35% | +7.52% | +2.92% | +10.64% | +29.69% | +63.10% | +48.56% | +138.00% | 20TCr | |
| -1.19% | -2.59% | -8.02% | -14.25% | -3.29% | -0.66% | -34.35% | -38.51% | -31.61% | 14TCr | |
| -0.58% | +6.04% | +10.99% | +11.24% | +9.57% | +11.57% | +41.15% | +146.36% | +477.46% | 13TCr | |
| -1.61% | +3.76% | +0.77% | -5.00% | +6.82% | +24.48% | -9.90% | -13.77% | -21.66% | 12TCr | |
| +0.49% | +1.74% | +7.68% | -5.84% | +8.74% | +40.46% | +43.08% | +10.38% | -0.80% | 10TCr | |
| -0.68% | +1.39% | +0.55% | -10.02% | -9.85% | -10.23% | -24.11% | -15.70% | -0.60% | 10TCr | |
| -3.36% | -2.92% | -5.00% | -19.10% | -11.67% | +0.61% | +76.55% | +66.12% | +485.60% | 7.63TCr | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 6.37TCr | |
| -1.68% | +6.25% | +3.69% | -5.76% | -12.64% | +0.27% | +8.64% | -23.44% | +249.75% | 5.07TCr | |
| -0.10% | +0.90% | +5.51% | -12.53% | +6.51% | +17.21% | +13.26% | +37.77% | +16.04% | 5.01TCr | |
| +0.75% | +0.77% | +7.31% | -5.60% | -6.43% | -6.63% | +9.34% | - | - | 4.07TCr | |
| +2.56% | +4.46% | -0.31% | -9.02% | -24.30% | -7.68% | +58.49% | +77.58% | +442.49% | 4.02TCr | |
| Average | -0.47% | +3.70% | +4.85% | +0.33% | +2.13% | +17.78% | +35.12% | +61.56% | +223.54% | 22.53TCr | |
| Weighted average by Cap. | -1.00% | +5.78% | +7.67% | +9.94% | +8.58% | +34.43% | +66.00% | +140.41% | +451.36% |
- Stock Market
- Stocks
- GILD Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
